Dark

VRTX
Vertex Pharmaceuticals Inc
stock NASDAQ

At Close

Feb 5, 2026 3:59:58 PM EST

458.76USD-2.499%(-11.76)1,672,961

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 5, 2026 9:07:30 AM EST

476.00USD+1.165%(+5.48)102

After-hours

Feb 5, 2026 4:58:30 PM EST

463.86USD+1.112%(+5.10)7,524

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

116.35B

Headquarters

Boston, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Feb 12, 2026 (6d)

Last Split

Aug 24, 20002for1

GILD BMY JNJ MRK ABBV ENTA XLV

VRTX Stats

Avg. Vol. 10 Day

1,311,628

Avg. Vol. 30 Day

1,273,593

Employees

2,300

Market Cap

116,352,918,708

Shares Out.

253,718,831

On/Off Exchange

54%/46%

6 Month Beta

0.51

1 Year Beta

0.44

2 Year Beta

0.49

3 Year Beta

0.54

52 Week Low

362.50

52 Week High

519.68

SMA50

454.65

SMA200

436.35

1 Week

-3.59%

1 Month

+2.18%

3 Month

+9.97%

6 Month

+22.30%

1 Year

-6.11%

2 Year

+6.93%

5 Year

+113.04%

Profile

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

VRTX Stock Summary

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock price today is $458.76, and today's volume is 1,672,961. VRTX is down -2.499% today. The 30 day average volume is 1,273,593. VRTX market cap is 116.35B with 253,718,831 shares outstanding.